Journal of International Oncology››2023,Vol. 50››Issue (2): 126-128.doi:10.3760/cma.j.cn371439-20220328-00026
Received:2022-03-28Revised:2022-06-20Online:2023-02-08Published:2023-03-22
"
"
| [1] | Weng G, Li F, Xu M. Pilomatrix carcinoma of the male breast: a case report[J]. Int J Clin Exp Pathol, 2020, 13(8): 2153-2157. |
| [2] | Lopansri S, Mihm MC Jr. Pilomatrix carcinoma or calcifying epitheliocarcinoma of Malherbe: a case report and review of literature[J]. Cancer, 1980, 45(9): 2368-2373. DOI: 10.1002/1097-0142. doi:10.1002/1097-0142pmid:7379033 |
| [3] | White C, Farsi M, Esguerra D, et al. Not your average skin cancer: a rare case of pilomatrix carcinoma[J]. J Clin Aesthet Dermatol, 2020, 13(6): 40-42. |
| [4] | Melancon JM, Tom WL, Lee RA, et al. Management of pilomatrix carcinoma: a case report of successful treatment with Mohs micrographic surgery and review of the literature[J]. Dermatol Surg, 2011, 37(12): 1798-1805. DOI: 10.1111/j.1524-4725.2011.02170.x. doi:10.1111/j.1524-4725.2011.02170.xpmid:22093235 |
| [5] | Alcántara-González J, Sánchez-Largo ME, Caminoa A, et al. Pilomatrix carcinoma: a rare cause of facial tumor[J]. Dermatol Online J, 2014, 20(7): 13030/qt5ct4m4w1. DOI: 10.5070/D3207023135. doi:10.5070/D3207023135 |
| [6] | Lazar AJ, Calonje E, Grayson W, et al. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin[J]. J Cutan Pathol, 2005, 32(2): 148-157. DOI: 10.1111/j.0303-6987.2005.00267.x. doi:10.1111/j.0303-6987.2005.00267.xpmid:15606674 |
| [7] | Aherne NJ, Fitzpatrick DA, Gibbons D, et al. Recurrent malignant pilomatrixoma invading the cranial cavity: improved local control with adjuvant radiation[J]. J Med Imaging Radiat Oncol, 2009, 53(1): 139-141. DOI: 10.1111/j.1754-9485.2009.02049.x. doi:10.1111/j.1754-9485.2009.02049.x |
| [8] | Papadakis M, de Bree E, Floros N, et al. Pilomatrix carcinoma: more malignant biological behavior than was considered in the past[J]. Mol Clin Oncol, 2017, 6(3): 415-418. DOI: 10.3892/mco.2017.1148. doi:10.3892/mco.2017.1148pmid:28451423 |
| [9] | Ng WT, Lee MC, Chang AT, et al. The impact of dosimetric in-adequacy on treatment outcome of nasopharyngeal carcinoma with IMRT[J]. Oral Oncol, 2014, 50(5): 506-512. DOI: 10.1016/j.oraloncology.2014.01.017. doi:10.1016/j.oraloncology.2014.01.017 |
| [10] | Thamlikitkul L, Petsuksiri J, Ithimakin S. Post-operative concurrent chemoradiation for patients with non-squamous cell carcinoma of head and neck: a retrospective cohort of the uncommon cancers[J]. Asian Pac J Cancer Prev, 2019, 20(6): 1727-1734. DOI: 10.31557/APJCP.2019.20.6.1727. doi:10.31557/APJCP.2019.20.6.1727 |
| [11] | Onderdonk BE, Vokes EE, Gwede M, et al. Adjuvant treatment for high-risk salivary gland malignancies and prognostic stratification based on a 20-year single institution experience[J]. Health Sci Rep, 2020, 3(4): e195. DOI: 10.1002/hsr2.195. doi:10.1002/hsr2.195pmid:33043152 |
| No related articles found! |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
